全文获取类型
收费全文 | 2701篇 |
免费 | 209篇 |
国内免费 | 2篇 |
专业分类
2912篇 |
出版年
2023年 | 7篇 |
2022年 | 22篇 |
2021年 | 45篇 |
2020年 | 21篇 |
2019年 | 22篇 |
2018年 | 45篇 |
2017年 | 31篇 |
2016年 | 81篇 |
2015年 | 139篇 |
2014年 | 145篇 |
2013年 | 192篇 |
2012年 | 236篇 |
2011年 | 233篇 |
2010年 | 160篇 |
2009年 | 145篇 |
2008年 | 166篇 |
2007年 | 175篇 |
2006年 | 137篇 |
2005年 | 143篇 |
2004年 | 133篇 |
2003年 | 110篇 |
2002年 | 106篇 |
2001年 | 28篇 |
2000年 | 18篇 |
1999年 | 16篇 |
1998年 | 36篇 |
1997年 | 32篇 |
1996年 | 19篇 |
1995年 | 25篇 |
1994年 | 17篇 |
1993年 | 19篇 |
1992年 | 12篇 |
1991年 | 14篇 |
1990年 | 6篇 |
1989年 | 9篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 5篇 |
1985年 | 12篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 26篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 10篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1971年 | 5篇 |
排序方式: 共有2912条查询结果,搜索用时 15 毫秒
991.
Randy Hecht Yue-Sheng Li Jeonghoon Sun Ed Belouski Michael Hall Todd Hager Junming Yie Wei Wang Dwight Winters Stephen Smith Chris Spahr Lei-Ting Tam Zhongnan Shen Shanaka Stanislaus Narumol Chinookoswong Yvonne Lau Allen Sickmier Mark Leo Michaels Thomas Boone Murielle M. Véniant Jing Xu 《PloS one》2012,7(11)
Fibroblast growth factor 21 (FGF21) is a promising drug candidate for the treatment of type 2 diabetes. However, the use of wild type native FGF21 is challenging due to several limitations. Among these are its short half-life, its susceptibility to in vivo proteolytic degradation and its propensity to in vitro aggregation. We here describe a rationale-based protein engineering approach to generate a potent long-acting FGF21 analog with improved resistance to proteolysis and aggregation. A recombinant Fc-FGF21 fusion protein was constructed by fusing the Fc domain of human IgG1 to the N-terminus of human mature FGF21 via a linker peptide. The Fc positioned at the N-terminus was determined to be superior to the C-terminus as the N-terminal Fc fusion retained the βKlotho binding affinity and the in vitro and in vivo potency similar to native FGF21. Two specific point mutations were introduced into FGF21. The leucine to arginine substitution at position 98 (L98R) suppressed FGF21 aggregation at high concentrations and elevated temperatures. The proline to glycine replacement at position 171 (P171G) eliminated a site-specific proteolytic cleavage of FGF21 identified in mice and cynomolgus monkeys. The derived Fc-FGF21(RG) molecule demonstrated a significantly improved circulating half-life while maintaining the in vitro activity similar to that of wild type protein. The half-life of Fc-FGF21(RG) was 11 h in mice and 30 h in monkeys as compared to 1-2 h for native FGF21 or Fc-FGF21 wild type. A single administration of Fc-FGF21(RG) in diabetic mice resulted in a sustained reduction in blood glucose levels and body weight gains up to 5-7 days, whereas the efficacy of FGF21 or Fc-FGF21 lasted only for 1 day. In summary, we engineered a potent and efficacious long-acting FGF21 analog with a favorable pharmaceutical property for potential clinical development. 相似文献
992.
Whole exome sequencing provides unprecedented opportunities to identify causative DNA variants in rare Mendelian disorders. Finding the responsible mutation via traditional methods in families with hearing loss is difficult due to a high degree of genetic heterogeneity. In this study we combined autozygosity mapping and whole exome sequencing in a family with 3 affected children having nonsyndromic hearing loss born to consanguineous parents. Two novel missense homozygous variants, c.508C>A (p.H170N) in GIPC3 and c.1328C>T (p.T443M) in ZNF57, were identified in the same ~6 Mb autozygous region on chromosome 19 in affected members of the family. Both variants co-segregated with the phenotype and were absent in 335 ethnicity-matched controls. Biallelic GIPC3 mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural hearing loss. Thus we conclude that the hearing loss in the family described in this report is caused by a novel missense mutation in GIPC3. Identified variant in GIPC3 had a low read depth, which was initially filtered out during the analysis leaving ZNF57 as the only potential causative gene. This study highlights some of the challenges in the analyses of whole exome data in the bid to establish the true causative variant in Mendelian disease. 相似文献
993.
van Vliet-Ostaptchouk JV van Haeften TW Landman GW Reiling E Kleefstra N Bilo HJ Klungel OH de Boer A van Diemen CC Wijmenga C Boezen HM Dekker JM van 't Riet E Nijpels G Welschen LM Zavrelova H Bruin EJ Elbers CC Bauer F Onland-Moret NC van der Schouw YT Grobbee DE Spijkerman AM van der A DL Simonis-Bik AM Eekhoff EM Diamant M Kramer MH Boomsma DI de Geus EJ Willemsen G Slagboom PE Hofker MH 't Hart LM 《PloS one》2012,7(3):e32148
Background
Genome-wide association studies in Japanese populations recently identified common variants in the KCNQ1 gene to be associated with type 2 diabetes. We examined the association of these variants within KCNQ1 with type 2 diabetes in a Dutch population, investigated their effects on insulin secretion and metabolic traits and on the risk of developing complications in type 2 diabetes patients.Methodology
The KCNQ1 variants rs151290, rs2237892, and rs2237895 were genotyped in a total of 4620 type 2 diabetes patients and 5285 healthy controls from the Netherlands. Data on macrovascular complications, nephropathy and retinopathy were available in a subset of diabetic patients. Association between genotype and insulin secretion/action was assessed in the additional sample of 335 individuals who underwent a hyperglycaemic clamp.Principal Findings
We found that all the genotyped KCNQ1 variants were significantly associated with type 2 diabetes in our Dutch population, and the association of rs151290 was the strongest (OR 1.20, 95% CI 1.07–1.35, p = 0.002). The risk C-allele of rs151290 was nominally associated with reduced first-phase glucose-stimulated insulin secretion, while the non-risk T-allele of rs2237892 was significantly correlated with increased second-phase glucose-stimulated insulin secretion (p = 0.025 and 0.0016, respectively). In addition, the risk C-allele of rs2237892 was associated with higher LDL and total cholesterol levels (p = 0.015 and 0.003, respectively). We found no evidence for an association of KCNQ1 with diabetic complications.Conclusions
Common variants in the KCNQ1 gene are associated with type 2 diabetes in a Dutch population, which can be explained at least in part by an effect on insulin secretion. Furthermore, our data suggest that KCNQ1 is also associated with lipid metabolism. 相似文献994.
In herbaceous ecosystems worldwide, biodiversity has been negatively impacted by changed grazing regimes and nutrient enrichment. Altered disturbance regimes are thought to favour invasive species that have a high phenotypic plasticity, although most studies measure plasticity under controlled conditions in the greenhouse and then assume plasticity is an advantage in the field. Here, we compare trait plasticity between three co-occurring, C(4) perennial grass species, an invader Eragrostis curvula, and natives Eragrostis sororia and Aristida personata to grazing and fertilizer in a three-year field trial. We measured abundances and several leaf traits known to correlate with strategies used by plants to fix carbon and acquire resources, i.e. specific leaf area (SLA), leaf dry matter content (LDMC), leaf nutrient concentrations (N, C:N, P), assimilation rates (Amax) and photosynthetic nitrogen use efficiency (PNUE). In the control treatment (grazed only), trait values for SLA, leaf C:N ratios, Amax and PNUE differed significantly between the three grass species. When trait values were compared across treatments, E. curvula showed higher trait plasticity than the native grasses, and this correlated with an increase in abundance across all but the grazed/fertilized treatment. The native grasses showed little trait plasticity in response to the treatments. Aristida personata decreased significantly in the treatments where E. curvula increased, and E. sororia abundance increased possibly due to increased rainfall and not in response to treatments or invader abundance. Overall, we found that plasticity did not favour an increase in abundance of E. curvula under the grazed/fertilized treatment likely because leaf nutrient contents increased and subsequently its' palatability to consumers. E. curvula also displayed a higher resource use efficiency than the native grasses. These findings suggest resource conditions and disturbance regimes can be manipulated to disadvantage the success of even plastic exotic species. 相似文献
995.
Yvonne E. Thomassen Joyce E. van der Welle Gerco van Eikenhorst Leo A. van der Pol Wilfried A.M. Bakker 《Process Biochemistry》2012,47(2):288-296
Rapid and simple cell and virus cultivation can currently be carried out using disposable bioreactors. The CELL-tainer® (CELLution Biotech BV) disposable bioreactor is a rocking-type bioreactor which not only has vertical movement but horizontal displacement as well. Due to this two-directional movement relatively high mass-transfer capacities can be reached when compared with conventional rocking motion-type bioreactors.Using the design of experiments (DoE) approach we have developed models for the mixing times in both the CELL-tainer® and the BIOSTAT® CultiBag RM (Sartorius Stedim Biotech) bioreactor (standard rocking motion-type). The conditions for cultivation of Vero cells in the CELL-tainer® bioreactor were chosen based on comparable mixing times.Vero cells growing adherent to Cytodex 1 microcarriers were cultivated in the CELL-tainer® and in the BIOSTAT® CultiBag RM. Both bioreactors were controlled with regard to temperature, pH and % dissolved oxygen. Vero cell growth in both bioreactors was comparable with respect to the growth characteristics and main metabolite production and consumption rates. Additionally, polio virus production in both bioreactors was shown to be similar. 相似文献
996.
Odile T. Bruggisser Nadine Sandau Gilles Blandenier Yvonne Fabian Patrik Kehrli Alex Aebi Russell E. Naisbit Louis-Félix Bersier 《Basic and Applied Ecology》2012,13(8):706-714
Species abundance in local communities is determined by bottom-up and top-down processes, which can act directly and indirectly on the focal species. Studies examining these effects simultaneously are rare. Here we explore the direct top-down and direct and indirect bottom-up forces regulating the abundance and predation success of an intermediate predator, the web-building spider Argiope bruennichi (Araneae: Araneidae). We manipulated plant diversity (2, 6, 12 or 20 sown species) in 9 wildflower strips in a region of intensive farmland. To identify the major factors regulating the distribution and abundance of A. bruennichi, we quantified three characteristics of vegetation (species diversity, composition and vegetation structure) as well as the spider's prey community and natural enemies. The distribution and abundance of A. bruennichi was regulated by combined bottom-up and top-down processes as well as by direct and indirect interactions between trophic levels. Four main factors were identified: (1) the strong direct effect of vegetation structure, (2) the positive effect of plant species diversity, which affected spider abundance directly and indirectly through increased densities and size of flower-visiting prey species, (3) the positive or negative direct effects of different plant species, and (4) the strongly negative direct effect of predacious hornets. The advantage of taking a global approach to understand the regulation of species abundance is highlighted first by the quantification of the relative importance of factors, with a surprisingly strong effect of hornet predators, and second by the discovery of a direct effect of plant diversity, which raises intriguing questions about habitat selection by this spider. 相似文献
997.
Yvonne R. Freund Tsutomu Akama M.R.K. Alley Joana Antunes Chen Dong Kurt Jarnagin Richard Kimura James A. Nieman Kirk R. Maples Jacob J. Plattner Fernando Rock Rashmi Sharma Rajeshwar Singh Virginia Sanders Yasheen Zhou 《FEBS letters》2012,586(19):3410-3414
We have used boron-based molecules to create novel, competitive, reversible inhibitors of phosphodiesterase 4 (PDE4). The co-crystal structure reveals a binding configuration which is unique compared to classical catechol PDE4 inhibitors, with boron binding to the activated water in the bimetal center. These phenoxybenzoxaboroles can be optimized to generate submicromolar potency enzyme inhibitors, which inhibit TNF-α, IL-2, IFN-γ, IL-5 and IL-10 activities in vitro and show safety and efficacy for topical treatment of human psoriasis. They provide a valuable new route for creating novel potent anti-PDE4 inhibitors. 相似文献
998.
Van der Velden J Janssen-Heininger YM Mandalapu S Scheller EV Kolls JK Alcorn JF 《PloS one》2012,7(4):e34638
The c-Jun N-terminal kinase (JNK) - 1 pathway has been implicated in the cellular response to stress in many tissues and models. JNK1 is known to play a role in a variety of signaling cascades, including those involved in lung disease pathogenesis. Recently, a role for JNK1 signaling in immune cell function has emerged. The goal of the present study was to determine the role of JNK1 in host defense against both bacterial and viral pneumonia, as well as the impact of JNK1 signaling on IL-17 mediated immunity. Wild type (WT) and JNK1 -/- mice were challenged with Escherichia coli, Staphylococcus aureus, or Influenza A. In addition, WT and JNK1 -/- mice and epithelial cells were stimulated with IL-17A. The impact of JNK1 deletion on pathogen clearance, inflammation, and histopathology was assessed. JNK1 was required for clearance of E. coli, inflammatory cell recruitment, and cytokine production. Interestingly, JNK1 deletion had only a small impact on the host response to S. aureus. JNK1 -/- mice had decreased Influenza A burden in viral pneumonia, yet displayed worsened morbidity. Finally, JNK1 was required for IL-17A mediated induction of inflammatory cytokines and antimicrobial peptides both in epithelial cells and the lung. These data identify JNK1 as an important signaling molecule in host defense and demonstrate a pathogen specific role in disease. Manipulation of the JNK1 pathway may represent a novel therapeutic target in pneumonia. 相似文献
999.
Yvonne J. Rosenberg Kelly Garcia Justin Diener Dennis Sullivan Scott Donahue Lingjun Mao Jonathan Lees Xiaoming Jiang Lori A. Urban Jeremiah D. Momper Kwok-Yiu Ho Palmer Taylor 《Journal of neurochemistry》2024,168(4):370-380
Millions of individuals globally suffer from inadvertent, occupational or self-harm exposures from organophosphate (OP) insecticides, significantly impacting human health. Similar to nerve agents, insecticides are neurotoxins that target and inhibit acetylcholinesterase (AChE) in central and peripheral synapses in the cholinergic nervous system. Post-exposure therapeutic countermeasures generally include administration of atropine with an oxime to reactivate the OP-inhibited AChE. However, animal model studies and recent clinical trials using insecticide-poisoned individuals have shown minimal clinical benefits of the currently approved oximes and their efficacy as antidotes has been debated. Currently used oximes either reactivate poorly, do not readily cross the blood–brain barrier (BBB), or are rapidly cleared from the circulation and must be repeatedly administered. Zwitterionic oximes of unbranched and simplified structure, for example RS194B, have been developed that efficiently cross the BBB resulting in reactivation of OP-inhibited AChE and dramatic reversal of severe clinical symptoms in mice and macaques exposed to OP insecticides or nerve agents. Thus, a single IM injection of RS194B has been shown to rapidly restore blood AChE and butyrylcholinesterase (BChE) activity, reverse cholinergic symptoms, and prevent death in macaques following lethal inhaled sarin and paraoxon exposure. The present macaque studies extend these findings and assess the ability of post-exposure RS194B treatment to counteract oral poisoning by highly toxic diethylphosphorothioate insecticides such as parathion and chlorpyrifos. These OPs require conversion by P450 in the liver of the inactive thions to the active toxic oxon forms, and once again demonstrated RS194B efficacy to reactivate and alleviate clinical symptoms within 60 mins of a single IM administration. Furthermore, when delivered orally, the Tmax of RS194B at 1–2 h was in the same range as those administered IM but were maintained in the circulation for longer periods greatly facilitating the use of RS194B as a non-invasive treatment, especially in isolated rural settings.
1000.
We reported the discovery of potent antioxidants based on magnolol, a naturally occurring biphenolic obtained from the bark of Magnolia officinalis. The allylmagnolols 3a,b were synthesized via O-alkylation of the biphenols followed by Claisen rearrangement. In-vitro using enhanced chemiluminescence (CL) and flow cytometric assays in whole cells revealed that both 3a and 3b displayed promising free radical scavenging effects in PMA- and LPS-stimulated models as compared with magnolol. Further DNA labeling analysis for cytotoxicity indicated that these analogues show no cytotoxic effects for the scavenging of the oxygen-derived free radicals under PMA-stimulated concentrations. The results from 3,3'-bisallylmagnolol (3b) suggested that the naturally occurring constituent was suitable to be a lead compound for the development of potential antioxidants for certain diseases. 相似文献